array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(29) "Regeneron Pharmaceuticals Inc"
["slug"]=>
string(38) "c469a-us-regeneron-pharmaceuticals-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/b5187988-884a-43b7-980d-e1555548ab77"
["description"]=>
string(868) "At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in.
Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media.
An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media. "
["address_street"]=>
string(25) "777 Old Saw Mill River Rd"
["address_place"]=>
string(9) "Tarrytown"
["address_region"]=>
string(8) "New York"
["founding_date"]=>
string(10) "1988-02-08"
["website_domain"]=>
string(13) "regeneron.com"
["website_url"]=>
string(25) "https://www.regeneron.com"
["industry_codes"]=>
array(1) {
[0]=>
string(27) "Pharmaceutical Preparations"
}
["employee_count"]=>
int(10368)
["article_count"]=>
int(2436)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(32) "Health Care Roundup: Market Talk"
["snippet_en"]=>
string(134) "Find insight on Helen of Troy, Sanofi, Regeneron Pharmaceuticals and more in the latest Market Talks covering the Health Care sector."
["url"]=>
string(74) "https://www.wsj.com/health/pharma/health-care-roundup-market-talk-9be34cf2"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/677d9872-b550-40fd-8cd7-8862120f1ed8"
["source"]=>
string(7) "wsj.com"
["publication_date"]=>
string(10) "2024-01-08"
["categories"]=>
array(5) {
[0]=>
string(11) "Competition"
[1]=>
string(16) "Customer Welfare"
[2]=>
string(24) "Access and affordability"
[3]=>
string(15) "Market Movement"
[4]=>
string(24) "Employee Health & Safety"
}
}
[1]=>
array(7) {
["title_en"]=>
string(107) "Daily Update: SWR students submit research projects to Regeneron talent competition - Riverhead News Review"
["snippet_en"]=>
string(300) "Here are the headlines for December 6, 2023. RIVERHEAD NEWS-REVIEW Shoreham-Wading River High School students submit research projects to Regeneron Science Talent Search Competition THE SUFFOLK TIMES CAST to hold free bilingual Christmas show this Friday SHELTER ISLAND REPORTER Bringing Christmas to"
["url"]=>
string(142) "https://riverheadnewsreview.timesreview.com/2023/12/118397/daily-update-swr-students-submit-research-projects-to-regeneron-talent-competition/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/c1b6b1ff-ad05-4afd-b8ba-5316fb94b358"
["source"]=>
string(15) "timesreview.com"
["publication_date"]=>
string(10) "2023-12-06"
["categories"]=>
array(3) {
[0]=>
string(11) "Competition"
[1]=>
string(17) "Academic Research"
[2]=>
string(14) "Product Review"
}
}
[2]=>
array(7) {
["title_en"]=>
string(72) "Commit To Buy Regeneron Pharmaceuticals At $470, Earn 2.7% Using Options"
["snippet_en"]=>
string(277) "Investors considering a purchase of Regeneron Pharmaceuticals, Inc. (Symbol: REGN) stock, but tentative about paying the going market price of $832.12/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put con"
["url"]=>
string(102) "https://www.nasdaq.com/articles/commit-to-buy-regeneron-pharmaceuticals-at-$470-earn-2.7-using-options"
["image_url"]=>
NULL
["source"]=>
string(10) "nasdaq.com"
["publication_date"]=>
string(10) "2023-10-11"
["categories"]=>
array(6) {
[0]=>
string(11) "Competition"
[1]=>
string(9) "Investors"
[2]=>
string(12) "Stock Market"
[3]=>
string(15) "Market Movement"
[4]=>
string(18) "General Investment"
[5]=>
string(11) "Acquisition"
}
}
[3]=>
array(7) {
["title_en"]=>
string(186) "Recombinant Therapeutic Protein Market To Witness the Highest Growth Globally in Coming Years 2023-2030 | Boehringer Ingelheim, Regeneron Pharmaceuticals, Eli Liily, Bristol-Myers Squibb"
["snippet_en"]=>
string(96) "The global Recombinant Therapeutic Protein Market has witnessed significant recent developments,"
["url"]=>
string(233) "https://www.digitaljournal.com/pr/news/cdn-newswire/recombinant-therapeutic-protein-market-to-witness-the-highest-growth-globally-in-coming-years-2023-2030-boehringer-ingelheim-regeneron-pharmaceuticals-eli-liily-bristol-myers-squibb"
["image_url"]=>
NULL
["source"]=>
string(18) "digitaljournal.com"
["publication_date"]=>
string(10) "2023-10-05"
["categories"]=>
array(3) {
[0]=>
string(11) "Competition"
[1]=>
string(18) "Expansion & Growth"
[2]=>
string(15) "Market Movement"
}
}
[4]=>
array(7) {
["title_en"]=>
string(95) "Students from the West Pomeranian Voivodeship in the final of a prestigious science competition"
["snippet_en"]=>
string(129) "Explory 2023 Competition. Young talents from the West Pomeranian Voivodeship will also compete for victory in the National Final."
["url"]=>
string(101) "https://infoludek.pl/nauka/uczniowie-z-zachodniopomorskiego-w-finale-prestizowego-konkursu-naukowego/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/8d5ed3c8-923a-4272-93f3-12d4d7f2fa66"
["source"]=>
string(12) "infoludek.pl"
["publication_date"]=>
string(10) "2023-10-04"
["categories"]=>
array(2) {
[0]=>
string(11) "Competition"
[1]=>
string(22) "Business Certification"
}
}
[5]=>
array(7) {
["title_en"]=>
string(29) "Is Regeneron Stock a Buy Now?"
["snippet_en"]=>
string(197) "There's a lot going on with biotech giant Regeneron (NASDAQ: REGN) that may be of interest to investors. The company could soon face biosimilar competition from one of its key growth drivers, Eylea"
["url"]=>
string(99) "https://www.sharewise.com/de/news_articles/Is_Regeneron_Stock_a_Buy_Now_TheMotleyFool_20230825_1615"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/dfd20ea2-5c47-42d3-ad2b-e381497ccb96"
["source"]=>
string(13) "sharewise.com"
["publication_date"]=>
string(10) "2023-08-25"
["categories"]=>
array(4) {
[0]=>
string(11) "Competition"
[1]=>
string(24) "Stock Research & Ratings"
[2]=>
string(16) "Share Repurchase"
[3]=>
string(12) "Stock Market"
}
}
[6]=>
array(7) {
["title_en"]=>
string(57) "Hawaii students win 12 awards from world STEM competition"
["snippet_en"]=>
string(152) "Alex Lee from Iolani School and Amara Martin and Madison Murata, both from Kamehameha Schools, joined HNN’s Sunrise Weekends to talk about their work."
["url"]=>
string(94) "https://www.hawaiinewsnow.com/2023/05/28/hawaii-students-win-12-awards-world-stem-competition/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/868811bc-250e-43b8-af29-6b01adfc530b"
["source"]=>
string(17) "hawaiinewsnow.com"
["publication_date"]=>
string(10) "2023-05-28"
["categories"]=>
array(3) {
[0]=>
string(11) "Competition"
[1]=>
string(5) "Award"
[2]=>
string(5) "Event"
}
}
[7]=>
array(7) {
["title_en"]=>
string(70) "Regeneron's Eylea Drug Sales Hit by Competition From 'New Kid in Town'"
["snippet_en"]=>
string(221) "US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education."
["url"]=>
string(120) "https://money.usnews.com/investing/news/articles/2023-05-04/regeneron-beats-quarterly-profit-estimates-on-eylea-strength"
["image_url"]=>
NULL
["source"]=>
string(10) "usnews.com"
["publication_date"]=>
string(10) "2023-05-04"
["categories"]=>
array(1) {
[0]=>
string(11) "Competition"
}
}
[8]=>
array(7) {
["title_en"]=>
string(69) "Regeneron's Eylea drug misses sales estimates as competition heats up"
["snippet_en"]=>
string(152) "(Reuters) -Regeneron Pharmaceuticals Inc on Thursday reported first-quarter sales of blockbuster eye drug Eylea below Wall Street targets as competition"
["url"]=>
string(69) "https://shorenewsnetwork.com/2023/05/04/regenerons-eylea-drug-misses/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/1f2a353e-2fd4-450a-ba98-e21fc23045bf"
["source"]=>
string(20) "shorenewsnetwork.com"
["publication_date"]=>
string(10) "2023-05-04"
["categories"]=>
array(2) {
[0]=>
string(11) "Competition"
[1]=>
string(24) "Quarterly/Annual Figures"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(197)
}
[1]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(193)
}
[2]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(152)
}
[3]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(100)
}
[4]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(95)
}
[5]=>
array(2) {
["name"]=>
string(17) "Academic Research"
["count"]=>
int(83)
}
[6]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(70)
}
[7]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(61)
}
[8]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(51)
}
[9]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(50)
}
[10]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(46)
}
[11]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(44)
}
[12]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(35)
}
[13]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(35)
}
[14]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(34)
}
[15]=>
array(2) {
["name"]=>
string(46) "Management of Legal and Regulatory Environment"
["count"]=>
int(33)
}
[16]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(33)
}
[17]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(32)
}
[18]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(31)
}
[19]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(31)
}
[20]=>
array(2) {
["name"]=>
string(14) "Product Review"
["count"]=>
int(31)
}
[21]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(29)
}
[22]=>
array(2) {
["name"]=>
string(27) "Business Model & Innovation"
["count"]=>
int(29)
}
[23]=>
array(2) {
["name"]=>
string(8) "Verdicts"
["count"]=>
int(29)
}
[24]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(27)
}
[25]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(26)
}
[26]=>
array(2) {
["name"]=>
string(13) "Data Security"
["count"]=>
int(24)
}
[27]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(23)
}
[28]=>
array(2) {
["name"]=>
string(11) "Sponsorship"
["count"]=>
int(20)
}
[29]=>
array(2) {
["name"]=>
string(8) "Politics"
["count"]=>
int(20)
}
}
}
c469a-us-regeneron-pharmaceuticals-inc
Regeneron Pharmaceuticals Inc
Location
New York
Founded
1988-02-08
Website
https://www.regeneron.com
Articles
2436 Articles
Category
Pharmaceutical Preparations
Description
At Regeneron we believe that when the right idea finds the right team, powerful change is possible. As we work across our expanding global network to invent, develop and commercialize life-transforming medicines for people with serious diseases, we’re establishing new ways to think about science, manufacturing and commercialization. And new ways to think about health. Connect with us so we can learn more about you, and you can learn more about our biopharmaceutical medicines. And join us, as we build a future we believe in.
Please visit www.regeneron.com/social-media-terms for information on how to engage with us on social media.
An important note about privacy: Regeneron is committed to your privacy and will not ask for sensitive personal information such as social security number, date of birth or bank account details via email or social media.
Here are the headlines for December 6, 2023. RIVERHEAD NEWS-REVIEW Shoreham-Wading River High School students submit research projects to Regeneron Science Talent Search Competition THE SUFFOLK TIMES CAST to hold free bilingual Christmas show this Friday SHELTER ISLAND REPORTER Bringing Christmas to
Investors considering a purchase of Regeneron Pharmaceuticals, Inc. (Symbol: REGN) stock, but tentative about paying the going market price of $832.12/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put con
There's a lot going on with biotech giant Regeneron (NASDAQ: REGN) that may be of interest to investors. The company could soon face biosimilar competition from one of its key growth drivers, Eylea
US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.
(Reuters) -Regeneron Pharmaceuticals Inc on Thursday reported first-quarter sales of blockbuster eye drug Eylea below Wall Street targets as competition
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.